Follow on Telegram

Latest

Madison Square Garden Compiled Dossier on Facial Recognition Critics

Madison Square Garden has reportedly compiled a dossier on activists who spoke out against its facial recognition program. The document, titled "Facial Recognition Activists.docx," includes specific comments made by critics about the venue's use of the technology, as well as tweets that were critical of

Scientists Engineer Bacteria to Convert Plastic Bottles into Parkinson's Drug

Turning Plastic Waste into Medicine A team of researchers has achieved a remarkable feat by engineering bacteria that can convert plastic bottles into L-DOPA, the primary drug used to treat Parkinson's disease. This innovative process transforms polyethylene terephthalate (PET) plastic—a common material in single-use bottles—into the

Science Article

Science Digest: Space Exploration, Planetary Discoveries, and Biology Advances

Today's science news spans from the depths of space to changes within the human body. Webb finds clues to ancient origin of Comet 3I/ATLAS The James Webb Space Telescope has detected unusual chemical signatures in comet 3I/ATLAS, suggesting it may have formed in a very different

OpenEvidence Integrates FDA-Cleared AI for Heart Disease Detection

OpenEvidence has announced the integration of FDA-cleared artificial intelligence technology to assist in detecting heart disease. The AI system is designed to help healthcare providers identify signs of heart disease earlier and more accurately. FDA clearance indicates the technology has met regulatory standards for safety and effectiveness in clinical settings.

Unapproved Longevity Gene Therapy Bypasses FDA via Overseas Clinics

A US company is set to offer an unapproved gene therapy targeting the anti-ageing protein klotho through overseas clinics, according to reports. The therapy instructs cells to produce more klotho, a protein associated with longevity and cellular health. By operating outside US borders, the company aims to bypass FDA regulations

Cadence Raises $100 Million to Advance AI-Driven Chronic Disease Management

AI Platform Targets Chronic Disease Care Cadence has raised $100 million to further develop and deploy its regulated AI system for chronic disease management. The funding round will support the company's efforts to automate various aspects of chronic care, including patient monitoring, medication management, and care coordination. Regulatory

Google's Search Dominance Faces New Challenges in the AI Era

Google has dominated online search for over two decades, but the rise of AI-powered search alternatives is beginning to test that supremacy. As artificial intelligence reshapes how people find information online, advertisers and users are exploring new options that challenge the traditional search model. The shift reflects broader changes in